Korea Joongang Daily
Korea JoongAng Daily

Lotte Biologics looks to go public by 2027-28, build third plant

BARCELONA, Spain — Lotte Biologics, a biopharmaceutical contract manufacturer, aims to go public by around 2027 to 2028, according to its CEO.

2023-10-30

ST Pharm aims to lead oligonucleotide production by 2026

Bio-manufacturer ST Pharm is seeking to secure the world’s top-notch production capacity for oligonucleotide by 2026.

2023-10-29

Daewoong sets $745 million sales target for duo of new drugs

BARCELONA, Spain — Daewoong Pharmaceutical hopes to achieve $745 million in global sales with its new drugs Fexuclue, a gastroesophageal reflux medication, and Envlo, a diabetes treatment, by 2030.

2023-10-26

Samsung Biologics thrives with big deals, eyes ADC for future

Samsung Biologics continues to thrive in the biopharmaceutical industry, attributing its success to speed, quality, and delivery. The company saw an 18 percent increase in revenue in Q3 and raised its revenue forecast for the year.

2023-10-26

Prestige Bio to complete Korea's largest antibody drug R&D facility

Prestige Biopharma Group, a Singapore-based biopharmaceutical company, is building Korea’s largest antibody drug R&D facility in Busan.

2023-10-26

[INTERVIEW] SK pharmteco's new tech to expedite cell and gene therapy process

SK pharmteco is developing technology to reduce the manufacturing time for cell and gene therapy from a month to just two or three days, potentially reducing costs and making it more accessible.

2023-10-25

Samsung Biologics eyes Barcelona boost at world’s largest pharma show

Samsung Biologics is eyeing new opportunities in Barcelona as it showcases its fifth plant at the CPHI Worldwide 2023 event, the world's largest pharmaceutical trade show.

2023-10-25

CPHI Worldwide begins in Barcelona with Korean heavyweights

CPHI Worldwide, the largest pharmaceutical trade show, started in Barcelona with major Korean biopharma players in attendance. Over 2,500 companies from 170 countries are exhibiting.

2023-10-24

SK pharmteco to participate in CPhI Worldwide in Spain

SK pharmteco, SK Inc.'s contract bio-manufacturing subsidiary, will showcase its capabilities in small molecule APIs and cell and gene therapy at the CPhI Worldwide convention in Barcelona.

2023-10-18

Samsung Biologics wants half of the world's CMO business

MILAN, Italy — Samsung Biologics hopes to fill half the world's contract manufacturing organization (CMO) orders.

2021-11-11